Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing.

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the company pulled its application for a combo flu/COVID-19 shot, saying it would ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, ...

Recently, Moderna released more phase III data on their RSV mRNA vaccine, and the vaccine saw a 25% decline in efficacy after 8.6 months, while GSK's subunit RSV vaccine Arexvy saw a 7% decline ...

The "warp speed" assistance of the US government to help pharmaceutical companies create COVID-19 vaccines has been an amazing moonshot for science and civilization.It turned a small biotechnology ...

Moderna was ready to test its mRNA-1273 candidate vaccine in people about two months after receiving the genetic code of the virus from Chinese scientists. That's orders of magnitude faster than ...

Moderna’s mRNA vaccine reaches its final phase. Here's how it works. The biotech firm's leading candidate has just entered phase three clinical trials in the U.S. Find out why this vaccine ...